# SP16 SERPIN-like Peptide Administration in Healthy Individuals

> **NCT03651089** · PHASE1 · COMPLETED · sponsor: **Serpin Pharma, LLC** · enrollment: 24 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** SP16
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03651089
- **Lead sponsor:** Serpin Pharma, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-16
- **Primary completion:** 2019-01-15
- **Final completion:** 2019-01-23
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-07-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03651089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03651089, "SP16 SERPIN-like Peptide Administration in Healthy Individuals". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03651089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*